桥本甲状腺炎女性孕前促甲状腺激素水平与妊娠早期甲状腺功能
该前瞻性研究纳入260例桥本甲状腺炎孕妇,从孕前随访至妊娠终止,评估孕前促甲状腺激素(T0-TSH)持续≤2.5 mIU/L者妊娠早期甲状腺功能不全的患病率,并计算预测妊娠早期TSH>2.5 mIU/L和>4.0 mIU/L的最佳孕前TSH切点。结果显示约30%的孕妇妊娠早期TSH>2.5 mIU/L,孕前TSH超过切点者妊娠早期甲状腺功能不全风险显著增加。
要点
- 孕前TSH持续≤2.5 mIU/L的桥本甲状腺炎女性中,约30%妊娠早期TSH>2.5 mIU/L。
- 妊娠早期TSH>4.0 mIU/L在左甲状腺素治疗组为19.7%,未治疗组为10.1%(P=0.038)。
- 孕前TSH切点:左甲状腺素组1.24/1.74 mIU/L,未治疗组1.73/2.07 mIU/L,分别预测妊娠早期TSH>2.5/4.0 mIU/L。
核心结论
- 为保证妊娠早期TSH<2.5 mU/L,左甲状腺素治疗和未治疗的桥本甲状腺炎女性孕前TSH切点分别约为1.24 mU/L和1.73 mU/L,比妊娠期目标值低约50%和30%。
- 为保证妊娠早期TSH<4.0 mU/L,左甲状腺素治疗和未治疗的桥本甲状腺炎女性孕前TSH切点分别为1.74 mU/L和2.07 mU/L。
研究设计与样本
- 前瞻性研究,纳入260例桥本甲状腺炎孕妇(122例接受左甲状腺素治疗[甲状腺功能减退组],138例未治疗且甲状腺功能正常[甲状腺功能正常组]),从孕前随访至妊娠终止。
- 每4-6周检测血清TSH,绘制受试者工作特征(ROC)曲线确定预测妊娠早期TSH>2.5 mIU/L(诊断标准1)和>4.0 mIU/L(诊断标准2)的最佳孕前TSH切点。
主要发现
- 妊娠早期TSH>2.5 mIU/L者在甲状腺功能减退组和甲状腺功能正常组均约占30%。
- 妊娠早期TSH>4.0 mIU/L在甲状腺功能减退组为19.7%,在甲状腺功能正常组为10.1%(P=0.038)。
- 基于ROC的最佳孕前TSH切点:甲状腺功能减退组为1.24 mIU/L(诊断标准1)和1.74 mIU/L(诊断标准2);甲状腺功能正常组为1.73 mIU/L(诊断标准1)和2.07 mIU/L(诊断标准2)。
- 孕前TSH超过上述切点者妊娠早期甲状腺功能不全风险增加:甲状腺功能减退组OR 15.92(95%CI 5.06-50.15)和16.68(95%CI 5.13-54.24);甲状腺功能正常组OR 16.14(95%CI 6.47-40.30)和17.36(95%CI 4.30-70.08),分别对应诊断标准1和诊断标准2。
关键数值与推荐
- 诊断标准1:妊娠早期TSH>2.5 mIU/L。
- 诊断标准2:妊娠早期TSH>4.0 mIU/L。
- 孕前TSH切点:甲状腺功能减退组1.24 mIU/L(诊断标准1)、1.74 mIU/L(诊断标准2);甲状腺功能正常组1.73 mIU/L(诊断标准1)、2.07 mIU/L(诊断标准2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Preconception optimization of thyroid function in women with Hashimoto thyroiditis (HT) is highly recommended to prevent/reduce the risk of thyroid insufficiency at early gestation. OBJECTIVE: This work aimed to evaluate the prevalence of first-trimester thyroid insufficiency in HT women with preconception thyrotropin (T0-TSH) values consistently less than or equal to 2.5 mIU/L with or without levothyroxine (LT4) treatment, and to calculate T0-TSH cutoffs that best preconceptionally identified HT women requiring first-trimester LT4 adjustment/prescription. METHODS: Serum TSH was obtained at 4- to 6-week intervals from 260 HT pregnant women (122 on LT4 [Hypo-HT]; 138 euthyroid without LT4 [Eu-HT]), prospectively followed from preconception up to pregnancy term. Receiver operating characteristic (ROC) curves were plotted to identify T0-TSH cutoffs best predicting first-trimester TSH levels greater than 2.5 mIU/L (diagnostic criterion [DC] 1) and greater than 4.0 mIU/L (DC 2). RESULTS: At first trimester, TSH was greater than 2.5 mIU/L in approximately 30% of both Hypo-HT and Eu-HT women, and greater than 4.0 mIU/L in 19.7% Hypo-HT and 10.1% Eu-HT women (P = .038). The optimal ROC-based T0-TSH cutoffs found were 1.24 mIU/L/1.74 mIU/L in Hypo-HT, and 1.73 mIU/L/2.07 mIU/L in Eu-HT women, for DC 1 and DC 2, respectively. T0-TSH values exceeding these cutoffs resulted in a statistically significantly increased risk of first-trimester thyroid insufficiency (odds ratio [OR] [95% CI)] 15.92 [5.06-50.15] and 16.68 [5.13-54.24] in Hypo-HT; 16.14 [6.47-40.30] and 17.36 [4.30-70.08] in Eu-HT women, for DC 1 and DC 2, respectively). CONCLUSION: The preconception TSH cutoffs that guaranteed a first-trimester TSH less than 2.5 mU/L in hypothyroid- and euthyroid-HT women were, respectively, almost 50% (1.24 mU/L) and 30% (1.73 mU/L) lower than this gestational target, and 1.74 mU/L and 2.07 mU/L in hypothyroid- and euthyroid-HT women, respectively, for a gestational target of 4.0 mU/L.
引用
- Moleti M, Alibrandi A, Di Mauro M, et al. Preconception Thyrotropin Levels and Thyroid Function at Early Gestation in Women With Hashimoto Thyroiditis. J Clin Endocrinol Metab. 2023. PMID: 36620924. doi:10.1210/clinem/dgac748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。